Answers are grounded in this paper and cite their sources.
Editorial discusses lectins as key players in immune responses and their potential in targeting infections and autoimmune diseases.
Lectins are glycan-binding proteins that are involved in numerous biological processes including cell development, cell-cell interactions, signaling pathways, and the immune response. In innate immunity, lectins often act as pattern recognition receptors (PRRs) and recognize pathogen-associated molecular patterns (PAMPs), but also damage-associated molecular patterns (DAMPs). Thus, lectins may contribute to a protective immune response, for instance during infections, but they may also be involved in immune pathology, for instance during sterile inflammation. Main classes of lectins in innate immunity include C-type lectin receptors (CLRs), siglecs, and galectins. Due to the manifold functions of these different classes of lectins in antimicrobial defense as well as immune homeostasis, lectin targeting is a promising strategy to shape immune responses in the context of infections, autoimmunity, cancer, or vaccination.
No takes yet. Share an insight, caveat, or question.
Lepenies et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: